Safety and tolerability of high-intensity anticoagulation with bivalirudin during neuroendovascular procedures

Keyphrases

• Activated Clotting Time 30%
• Angiomax 10%
• Angioplasty 10%
• Anticoagulation 100%
• Arm Weakness 10%
• Bivalirudin 100%
• Bleeding Complications 30%
• Cost-effectiveness 10%
• Direct Thrombin Inhibitors 10%
• Dosing Regimen 10%
• Embolization Procedures 10%
• Groin Hematoma 10%
• Headache 10%
• Hemorrhagic Complications 10%
• Heparin 50%
• Heparin-induced Thrombocytopenia 10%
• High Dose 10%
• Interventional Cardiology 10%
• Ischemic Events 10%
• Left Arm 10%
• Low-dose Protocol 10%
• Major Haemorrhage 10%
• Middle Cerebral Artery 10%
• Safer Alternatives 10%
• Safety Profile 10%
• Short Half-life 10%
• Stent Placement 10%
• Thromboembolic Complications 20%
• Time Targets 10%
• Tolerability 100%
• Two-agent 10%
• Vascular Neurosurgery 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Arm Weakness 9%
• Bivalirudin 100%
• Bleeding 36%
• Clotting Time 27%
• Groin Hematoma 9%
• Headache 9%
• Hemoglobins 9%
• Heparin 45%
• Heparin Induced Thrombocytopenia 9%
• Thrombin Inhibitor 9%
• Thromboembolism 18%
• Tolerability 100%